Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Cardiology
Trial Title   Randomized Evaluation of Long term anticoagulant therapy comparing the efficacy and safety of dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
Description of Research   Patients with atrial fibrillation who are at a high risk of stroke may take a blood-thinning medication to reduce the risk of stroke. The purpose of this study is to evaluate how well Dabigatran etexilate works (at two different doses) and how safe it is, compared to warfarin, which is standard therapy for patients with atrial fibrillation.

Study Number   HSR 06-0650
Inclusion/Notes   Age 18 years or older
Documented atrial fibrillation
Must have additional risk factors for stroke
Additional screening criteria
Principal Investigator   Goraya MD, Tauqir
Contact Name   MYERS RN, DEBORAH
Fax   (734) 712-7244
Phone   (734) 712-7241
A Member of Trinity Health
© 2015 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456